galactose has been researched along with dapagliflozin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coady, MJ; Lapointe, JY; Wallendorff, B | 1 |
| Abdelkader, NF; Ibrahim, WW; Kamel, AS; Wahid, A | 1 |
2 other study(ies) available for galactose and dapagliflozin
| Article | Year |
|---|---|
Characterization of the transport activity of SGLT2/MAP17, the renal low-affinity Na
Topics: 3-O-Methylglucose; Animals; Benzhydryl Compounds; Biological Transport; Dose-Response Relationship, Drug; Galactose; Glucose; Glucosides; Humans; Kidney; Kinetics; Membrane Potentials; Membrane Proteins; Methylglucosides; Phlorhizin; Renal Reabsorption; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Xenopus laevis | 2017 |
Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/D-galactose Alzheimer's rat model.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Autophagy; Galactose; Rats; Sirtuin 1; Sodium-Glucose Transporter 2 Inhibitors; TOR Serine-Threonine Kinases | 2022 |